JESSICA ENG: Open Payments
NPI 1336477488 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,755 in 147 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $1,272 · 2025 $2,755
Food & beverage: $2,755
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $293 |
| Eisai Inc. | 11 | $275 |
| UCB, Inc. | 17 | $268 |
| PFIZER INC. | 25 | $243 |
| Teva Pharmaceuticals USA, Inc. | 6 | $220 |
| Lilly USA, LLC | 9 | $192 |
| Alexion Pharmaceuticals, Inc. | 3 | $181 |
| ARGENX US, INC. | 4 | $114 |
| Neurocrine BioSciences, Inc. | 5 | $99 |
| Lundbeck LLC | 4 | $86 |
Products named: Leqembi, ULTOMIRIS, NURTEC ODT, AUSTEDO XR, KISUNLA, QULIPTA, VYVGART HYTRULO, Briviact.
Industry payments across AZ — which companies pay providers there.
